XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 2,876 $ 4,258 $ 12,284 $ 21,287
General and administrative 2,125 4,490 22,869 14,294
Total operating expenses 5,001 8,748 35,153 35,581
Loss from operations (5,001) (8,748) (35,153) (35,581)
Other income (expense):        
Foreign currency gain (loss) (228) (1,317) 404 (2,516)
Interest income, net 1,261 383 3,271 615
Total other income (expense) 1,033 (934) 3,675 (1,901)
Net loss $ (3,968) $ (9,682) $ (31,478) $ (37,482)
Earnings Per Share, Basic $ (0.15) $ (0.37) $ (1.17) $ (1.43)
Earnings Per Share, Diluted $ (0.15) $ (0.37) $ (1.17) $ (1.43)
Weighted Average Number of Shares Outstanding, Basic 27,071,053 26,336,029 26,803,468 26,290,868
Weighted-average number of shares outstanding used to compute net loss per share, diluted 27,071,053 26,336,029 26,803,468 26,290,868
Comprehensive loss:        
Net loss $ (3,968) $ (9,682) $ (31,478) $ (37,482)
Other comprehensive loss        
Unrealized gain (loss) on investments, net of tax of $0 24 23 347 (458)
Comprehensive loss $ (3,944) $ (9,659) $ (31,131) $ (37,940)